Skip to content
Search

Latest Stories

Regular booster vaccines are the future in battle with Covid-19 virus, says UK genome expert

Regular booster vaccines are the future in battle with Covid-19 virus, says UK genome expert

REGULAR booster vaccines against the novel coronavirus will be needed because of mutations that make it more transmissible and better able to evade human immunity, said the head of Britain's effort to sequence the virus's genomes.

The novel coronavirus, which has killed 2.65 million people globally since it emerged in China in late 2019, mutates around once every two weeks, slower than influenza or HIV, but enough to require tweaks to vaccines.


Sharon Peacock, who heads Covid-19 Genomics UK (COG-UK) which has sequenced half of all the novel coronavirus genomes so far mapped globally, said international cooperation was needed in the "cat and mouse" battle with the virus

"We have to appreciate that we were always going to have to have booster doses; immunity to coronavirus doesn't last forever," Peacock told Reuters at the Wellcome Sanger Institute's 55-acre campus outside Cambridge.

"We already are tweaking the vaccines to deal with what the virus is doing in terms of evolution - so there are variants arising that have a combination of increased transmissibility and an ability to partially evade our immune response," she said.

Peacock said she was confident regular booster shots - such as for influenza - would be needed to deal with future variants but that the speed of vaccine innovation meant those shots could be developed at pace and rolled out to the population.

The COG-UK was set up by Peacock, a professor at Cambridge, exactly a year ago with the help of the British's government's chief scientific adviser, Patrick Vallance, as the virus spread across the globe to Britain.

It is now the world's biggest network of knowledge about the virus's genetics: At sites across Britain, it has sequenced 346,713 genomes of the virus out of a global effort of around 709,000 genomes.

On the intellectual frontline at the Wellcome Sanger Institute, hundreds of scientists - many with PhDs, many working on a voluntary basis and some listening to heavy metal or electronic beats - work seven days a week to map and then search the virus's growing family tree for patterns of concern.

Wellcome Sanger Institute has sequenced over half of the UK total sequenced genomes of the virus after processing 19 million samples from PCR tests in a year. COG-UK is sequencing around 30,000 genomes per week - more than the UK used to do in a year.

More For You

Minorities in England face 'lower prescribing rates for diabetes tech'

The disparity is particularly concerning as approximately 5.8 m people across the UK live with diabetes

iStock

Minorities in England face 'lower prescribing rates for diabetes tech'

Highlights

  • Ethnic minorities are less likely to receive continuous glucose monitors despite having higher diabetes rates.
  • People from minority backgrounds make up 17.5 per cent of populations in areas with below-average device prescribing.
  • Ethnicity and deprivation account for up to 77 per cent of variance in diabetes technology prescribing.

People from ethnic minority backgrounds in England have significantly less access to vital diabetes technology, despite being at greater risk of developing the condition, according to groundbreaking research.

The study, published in Diabetic Medicine, reveals that black and south Asian communities face significantly lower prescribing rates for continuous glucose monitors (CGMs) – devices that help people manage their blood glucose levels more effectively than traditional finger-prick tests.

Keep ReadingShow less